By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Happen Recently
  • Home
  • Startup
  • Industry
    • Technology
    • Health
    • Sports
    • Education
  • Funding
  • Leadership
  • Podcast
  • Magazine
Reading: AARISE Pharmaceuticals Advances Medical Treatments with New Tablets, Capsules, Syrups, and Injections
Share
Aa
Aa
Happen Recently
  • Funding
  • Leadership
  • Startup
  • Industry
  • International
  • Magazine
  • Home
  • Startup
  • Industry
    • Technology
    • Health
    • Sports
    • Education
  • Funding
  • Leadership
  • Podcast
  • Magazine
Brand Postmedical

AARISE Pharmaceuticals Advances Medical Treatments with New Tablets, Capsules, Syrups, and Injections

Team Happen Recently
Last updated: 2024/07/19 at 6:55 PM
Team Happen Recently
Share
4 Min Read
AARISE Pharmaceuticals
SHARE

Aarise Pharmaceuticals is a well-known Contract Development and Manufacturing Organization (CDMO) in the pharmaceutical industry, known for its technology-driven solutions. Aarise Pharmaceuticals has successfully launched more than 60 products worldwide, demonstrating expertise in addressing difficult dosing issues with their innovative taste-masking, customized release, and solubility enhancement technologies. They aim to revolutionize drug delivery and enhance the quality of life by offering efficient solutions for pharmacies, hospitals, medical practices, and biopharma companies. Aarise Pharmaceuticals provides a variety of products in different forms such as tablets, capsules, syrups, and injections, all created to address distinct medical requirements and enhance patient results.

Aarise Pharmaceuticals provides a range of tablets designed to target various health issues. The Aarimet 500mg Tablet is designed to efficiently regulate blood sugar levels to effectively treat diabetes. The ParaAarise 650 mg Tablet, which contains paracetamol, is commonly utilized to alleviate pain and decrease fever. These tablets are created using state-of-the-art technologies to guarantee maximum effectiveness and patient compliance.

Aarise Pharmaceuticals offers a variety of powerful formulations in their capsule range to address various therapeutic requirements. The OD-Aarise Capsules, containing Domperidone IP and Omeprazole IP, are prescribed for gastrointestinal issues to stop vomiting and lower stomach acid levels. The Omerise 20mg Capsule, which has Omeprazole as its active ingredient, is designed for treating acid reflux and GERD. The Pantadom Aarise Capsule, which combines Pantoprazole Sodium and Domperidone, helps alleviate acid-related problems and nausea. Moreover, the RD-Aarise Capsules provide comparable dual relief for digestive issues, containing Rabeprazole Sodium IP and Domperidone IP.

Aarise Pharmaceuticals’ syrups and suspensions are created for patients who struggle with swallowing tablets or need precise dosages. The Ams Aarise Syrup, which consists of Dried Aluminium Hydroxide Gel LP, Magnesium Hydroxide IP, and Simethicone IP, is utilized to relieve symptoms of indigestion and heartburn. The CYPRO-AP Plus Syrup acts as a beneficial appetite stimulant for patients who are underweight. The Levorise LS Syrup, containing Ambroxol Hydrochloride IP, Levosalbutamol Sulphate IP, and Guaifenesin IP, serves as a potent expectorant and bronchodilator for respiratory disorders. The Montel Aarise Suspension and Pararise 125 mg Suspension are both made up of Paracetamol IP 125 mg and are frequently utilized to treat symptoms of allergies and fever. Furthermore, the Pararise AP Suspension aims to offer comparable advantages with improved characteristics.

Aarise Pharmaceuticals offers a wide variety of injectable medications for different medical purposes as well. Ceftriaxone 1000 mg Injection and Ceftriaxone Sulbactam 1500 mg Injection are potent antibiotics prescribed for severe bacterial infections. The Cholecalciferol 7.5 mg Injection is used for supplementing vitamin D. The Diclofenac 25 mg and 75 mg Injections, which include Diclofenac, are utilized for their anti-inflammatory and pain-relieving effects. The injection of Drotaverine Hydrochloride 40 mg provides alleviation from smooth muscle contractions. The Furosemide 10 mg Injection, containing Furosemide, is a diuretic utilized to decrease fluid accumulation. The Gentamicin 40 mg Injection is a successful antibiotic for different types of bacterial infections. The Ondansetron 2 mg Injection prevents chemotherapy-induced nausea and vomiting, while the Pantoprazole 40 mg Injection treats stomach problems related to acid.

Aarise Pharmaceuticals is a reliable healthcare industry partner due to its dedication to enhancing patient care with innovative pharmaceutical solutions. Their diverse range of products guarantees healthcare providers have access to suitable treatments that cater to the specific requirements of their patients.

Aarise pharmaceuticals Company, Invite to investors, regarding investment in our company

To know more about Aarise Pharma Solutions and the services they offer, please visit their website or reach out to their customer service team.

You Might Also Like

Sumit Senapati: A Rising Creative Force Reviving Sambalpuri Culture Through Digital Content and Music

From Medicine to Innovation: How 24-Year-Old Dr. Sarwar Alam is Reshaping the Hair Care Business in Bihar.

Agartala Press Club Hosts Launch of Swarnakamal Jewellers’ “Vivah Swarna Utsav 2026”

SMMPanelOne and the Rising Demand for Scalable SMM Panel Solutions

FollowCube Emerges as a Cost-Effective SMM Panel Offering Scalable Social Media Growth Solutions.

TAGGED: AARISE Pharmaceuticals

Sign Up For Daily Newsletter

Be keep up! Get the latest breaking news delivered straight to your inbox.
[mc4wp_form]
By signing up, you agree to our Terms of Use and acknowledge the data practices in our Privacy Policy. You may unsubscribe at any time.
Team Happen Recently July 19, 2024
Share this Article
Facebook Twitter Copy Link Print
Previous Article Elisha Chowtapalli Empowering Women One Bag at a Time: The Inspiring Story of Elisha Chowtapalli and Promise Bags
Next Article New Study Forecasts ‘Unacceptably High’ Cancer Rates for Generation X; Here’s Why
Leave a comment Leave a comment

Leave a Reply Cancel reply

You must be logged in to post a comment.

HR

Happen Recently, the leading PR and news platform, has been making waves in the media industry under the dynamic leadership of its CEO, Shubham Pancheshwar. 

You can contact us at our email: connect@happenrecently.com

COMPANY

  • CONTACT US
  • TERMS & CONDITIONS
  • PRIVACY POLICY
  • ABOUT US
  • DISCLAIMER

CATEGORIES

  • LEADERSHIP
  • STARTUP
  • INDUSTRY
  • PODCAST
  • MAGAZINE

LATEST MAGAZINE

Subscribe Now
Facebook Twitter Youtube Instagram Linkedin

© 2025 Happen Recently. All Rights Reserved.

Go to mobile version
adbanner
AdBlock Detected
Our site is an advertising supported site. Please whitelist to support our site.
Okay, I'll Whitelist
Welcome Back!

Sign in to your account

Lost your password?